comparemela.com

Latest Breaking News On - Linical studies - Page 8 : comparemela.com

Nemolizumab Being Reviewed for AD, Prurigo Nodularis

For prurigo nodularis, the FDA has granted nemolizumab, a monoclonal antibody designed to inhibit interleukin-31 signaling, priority review.

Drug administrationEuropean medicines agencyBiologics license applicationMarketing authorization applicationsBiologic therapyPrurigo nodularisAtopic dermatitisAtopic eczemaMonoclonal antibodyAdolescent medicineAdolescent healthClinical researchClinical trialsLinical studiesPre clinical trialDouble blind study

Dupilumab for EoE: How Is it Improving Treatment?

The drug was a boon for many patients, mainly those with moderate to severe disease, but cost and insurance approvals posed challenges.

University of north carolinaNorth carolinaUnited statesNew yorkRegeneron sanofiPhilip katzEvan dellonDrug administrationUniversity of north carolina at chapel hillMajor advanceWeill cornell medicineNew york cityMedscape medicalNew england journalEsophageal diseasesChapel hill

FDA Approves First Cellular Therapy for Metastatic Melanoma

Lifileucel is the first cellular therapy to be approved to treat patients with unresectable or metastatic melanoma.

Allison betof warnerPeter marksMelanoma foundationSamanthar guildDrug administrationIovance biotherapeutics incBiologics evaluationBetof warnerMelanoma medical oncologyStanford medicineMalignant melanomaSkin cancerAlignant skin neoplasmClinical researchClinical trialsLinical studies

Nonablative RF Treatment Effective in Adults With Acne

The study is thought to be the first comprehensive analysis to evaluate NMRF as a treatment for acne, according to the authors.

Krung thep mahanakhonWoraphong manuskiattiDepartment of dermatology at siriraj hospitalMahidol universityDermatology life quality indexSiriraj hospitalAcne vulgarisAcneiform eruptionsSkin and soft tissue infectionLaser surgeryLaser therapyClinical researchClinical trialsLinical studiesPre clinical trialDouble blind study

Salt Substitute Reduces Risk for New Hypertension

Among older adults with normal blood pressure, replacing table salt with salt substitute reduced the incidence of hypertension vs a usual salt group, in the DECIDE-Salt trial.

Rhode islandUnited statesNoord hollandYangfeng wuAnkur shahOlde engberinkDivision of kidney diseaseUniversity clinical research instituteJournal of the american college cardiologyAmsterdam university medical centerWarren alpert medical school of brown universityPeking university clinical research instituteAmerican collegeKidney diseaseWarren alpert medical schoolBrown university

vimarsana © 2020. All Rights Reserved.